The FDA has pledged to update its policy on dietary supplements, promising "one of the most significant upgrades in the regulation and supervision of food supplements for over 25 years," according to a statement by FDA Commissioner Scott Gottlieb.
The FDA does not review food supplements before it reaches the market but can intervene when products are considered dangerous or carry false, misleading or unsubstantiated claims about their health benefits. The agency said these claims could cause real harm when people give up approved treatments that have proven safe and effective. Approximately three quarters of US consumers regularly take dietary supplements – including four out of five adults, says Gottlieb. Industry has risen from tens of thousands of products worth more than $ 40 billion, he added.
On Monday, the FDA sent 12 warning letters and five online consultation letters to companies that illegally sell their products as Alzheimer's. In recent months, the agency has also suffered a number of other products, including supplements for male enhancements and those who claim to treat opioid dependence.